Table 2.

Treatable Disorders Associated with Early Infantile-Onset Epileptic Encephalopathy

ConditionsGene(s)MOIClinical FindingsTreatment
Neuro-
metabolic
disorders
Pyridoxine-dependent epilepsy ALDH7A1 AR
  • ↑ plasma & urine alpha-aminoadipic semialdehyde
  • ↑ plasma & CSF pipecolic acid
Seizures/encephalopathy responsive to pyridoxine
Pyridoxamine 5'-phosphate oxidase deficiency (OMIM 610090) PNPO AR
  • Lactic acidemia
  • Hypoglycemia
Seizures/encephalopathy responsive to pyridoxal 5-prime phosphate
Biotinidase deficiency BTD AR
  • Deficient biotinidase enzyme activity in serum or plasma
  • Ketolactic acidosis, organic aciduria, hyperammonemia
  • Skin rash, alopecia, recurrent viral or fungal infections
Lifelong biotin supplementation
Glucose transporter 1 deficiency syndrome SLC2A1 AD
AR
  • ↓ CSF glucose concentration
  • Absence seizures beginning age <3
Ketogenic diet

Creatine deficiency syndromes

GAMT
GATM
SCL6A8
AR
XL
  • Cerebral creatine deficiency on brain MR spectroscopy
  • Suggestive ratio of guanidinoacetate, creatine, &/or creatinine in plasma & urine
Creatine monohydrate supplementation
Holocarboxylase synthetase deficiency (OMIM 253270) HLCS AR
  • Ketolactic acidosis, organic aciduria, hyperammonemia
  • Skin rash, alopecia
Responsive to biotin
Serine biosynthesis disorders PHGDH
PSAT1
PSPH
AR
  • Congenital or acquired microcephaly, congenital cataracts
  • ↓ plasma & CSF serine
L-serine & glycine supplementation can reduce seizures, improve psychomotor symptoms, & prevent progression depending on subtype
Other Infection of the CNSNAMRI, blood culture &/or lumbar puncture suggestive of infectionAntibiotic, antiviral, or antifungal therapy
Structural brain lesionsNA(Multi)focal lesions on brain MRI

Tuberous sclerosis complex

TSC1
TCS2
  • MRI brain lesions (subependymal nodules, subependymal giant cell astrocytomas, tubers, focal cortical dysplasias)
  • Cardiac rhabdomyoma, skin lesions, retinal lesions, renal lesions
Consideration of mTOR inhibitor for astrocytoma, additional seizure reduction
ARX-associated encephalopathy (OMIM 308350) ARX Enlarged ventricles & T2-weighted signals in basal ganglia on brain MRI

AD = autosomal dominant; AR = autosomal recessive; MOI = mode of inheritance; NA = not applicable; XL = X-linked

From: KCNT1-Related Epilepsy

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.